The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
Abstract
The current interest in leishmaniasis stems from the importance of this disease with respect to travel medicine, veterans of Operation Desert Storm, humanitarian concerns, and infection with human immunodeficiency virus. Herein, I review aspects of leishmaniasis that are of practical value to practitioners, including presentation, diagnosis, and chemotherapy; I will emphasize advances in chemotherapy over the last 10 years. Amphotericin B and its new lipid formulations are now competitive with pentavalent antimony as primary therapy for visceral leishmaniasis. Pentamidine, paromomycin, and adjunctive therapy with interferon-gamma are secondary regimens for the treatment of this condition. High-dose long-term regimens of antimony have been shown to be highly effective for the treatment of cutaneous leishmaniasis. Preliminary evidence of efficacy has been observed with short courses of pentamidine for the treatment of Leishmania braziliensis complex disease and topical paromomycin/methylbenzethonium chloride for the treatment of Leishmania major disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Perspectives on a Subclinical Form of Visceral Leishmaniasis
Badaro, R., Jones, T. C., Carvalho, E. M., Sampaio, D., Reed, S. G., Barral, A., Teixeira, R., & Johnson, W. D. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.6.1003 · Cited by 480
Interleukin 10 production correlates with pathology in human Leishmania donovani infections.
Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A., Siddig, M., Hashim, F. A., el-Hassan, A. M., Russo, D. M., & Reed, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116570 · Cited by 434
Lipid Formulations of Amphotericin B: Recent Progress and Future Directions
Hiemenz, J. W., & Walsh, T. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s133 · Cited by 404
Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future Strategies
Berman, J. D. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.3.560 · Cited by 380
Self-citationVisceral Infection Caused by Leishmania tropica in Veterans of Operation Desert Storm
Magill, A. J., Grogl, M., Gasser, R. A., Sun, W., & Oster, C. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281904 · Cited by 369
Cytokine patterns in the pathogenesis of human leishmaniasis.
Pirmez, C., Yamamura, M., Uyemura, K., Paes-Oliveira, M., Conceição-Silva, F., & Modlin, R. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116341 · Cited by 364
Estimation of population at risk of infection and number of cases of Leishmaniasis
Ashford, R. W., Desjeux, P., & deRaadt, P. (1992) · Parasitology Today · doi:10.1016/0169-4758(92)90249-2 · Cited by 356
Karp, C. L., el-Safi, S. H., Wynn, T. A., Satti, M. M., Kordofani, A. M., Hashim, F. A., Hag-Ali, M., Neva, F. A., Nutman, T. B., & Sacks, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116372 · Cited by 340
Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma
Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001043220104 · Cited by 310
An analysis of T cell responsiveness in Indian kala-azar.
Sacks, D. L., Lal, S. L., Shrivastava, S. N., Blackwell, J., & Neva, F. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.908 · Cited by 251
Zijlstra, E. E., El-Hassan, A. M., Ismael, A., & Ghalib, H. W. (1994) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.826 · Cited by 231
Practical progress and new drugs for changing patterns of leishmaniasis
Olliaro, P. L., & Bryceson, A. D. M. (1993) · Parasitology Today · doi:10.1016/0169-4758(93)90231-4 · Cited by 218
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068903 · Cited by 195
Chunge, C. N., Owate, J., Pamba, H. O., & Donno, L. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90263-e · Cited by 175
Melby, P. C., Andrade-Narvaez, F. J., Darnell, B. J., Valencia-Pacheco, G., Tryon, V. V., & Palomo-Cetina, A. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.837-842.1994 · Cited by 172
Short-Course Treatment of Visceral Leishmaniasis with Liposomal Amphotericin B (AmBisome)
Davidson, R. N., di Martino, L., Gradoni, L., Giacchino, R., Gaeta, G. B., Pempinello, R., Scotti, S., Cascio, A., Castagnola, E., Maisto, A., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.6.938 · Cited by 163
Seaman, J., Pryce, D. H., Sondorp, H. E., Moody, A. H., Bryceson, A. D. M., & Davidson, R. N. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.3.715 · Cited by 124
Ritter, U., Moll, H., Laskay, T., Bröcker, E. ‐., Velazco, O., Becker, I., & Gillitzer, R. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.3.699 · Cited by 120
Bowden, R. A., Cays, M., Gooley, T. A., Mamelok, R. D., & van Burik, J. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1208 · Cited by 117
Liposomal Amphotericin B (AmBisome) in the Treatment of Complicated Kala-Azar Under Field Conditions
Seaman, J., Boer, C., Wilkinson, R. J., de Jong, J., Wilde, E., Sondorp, E., & Davidson, R. N. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.188 · Cited by 109
Thakur, C. P., Kumar, M., Kumar, P., Mishra, B. N., & Pandey, A. K. (1988) · BMJ · doi:10.1136/bmj.296.6636.1557 · Cited by 99
Thakur, C. P., Pandey, A. K., Sinha, G. P., Roy, S., Behbehani, K., & Olliaro, P. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90271-0 · Cited by 96
Thakur, C. P., Olliaro, P., Gothoskar, S. V., Bhowmick, S., Choudhury, B., Prasad, S., Kumar, M., & Verma, B. B. (1992) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(92)90150-b · Cited by 92
Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan
Zijlstra, E. E., Ali, M. S., El-Hassan, A. M., Eltoum, I. A., Satti, M., Ghalib, H. W., & Kager, P. A. (1991) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(91)90224-m · Cited by 88
Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial.
Sn, J., Singh, N. K., & Tk, J. (1991) · PubMed · Cited by 85
Adhya, S., Chatterjee, M., Hassan, M. Q., Mukherjee, S., & Sen, S. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90416-6 · Cited by 69
Harms, G., Chehade, A. K., Douba, M., Roepke, M., Mouakeh, A., Rosenkaimer, F., & Bienzle, U. (1991) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(91)90026-u · Cited by 46
Larbi, E., Alkhawajah, A. M., Al‐Gindan, Y., Jain, S., Abahusain, A., & Alzayer, A. A. (1995) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1995.52.166 · Cited by 44
Cited by
Reithinger, R., Dujardin, J.-C., Louzir, H., Pirmez, C., Alexander, B., & Brooker, S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70209-8 · Cited by 1,334
Herwaldt, B. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10178-2 · Cited by 1,229
Oral Miltefosine for Indian Visceral Leishmaniasis
Sundar, S., Jha, T. K., Thakur, C. P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A., & Berman, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021556 · Cited by 779
Self-citationSundar, S., More, D. K., Singh, M. K., Singh, V. P., Sharma, S., Makharia, A., Kumar, P. C. K., & Murray, H. W. (2000) · Clinical Infectious Diseases · doi:10.1086/318121 · Cited by 664
Blood Groups in Infection and Host Susceptibility
Cooling, L. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-14 · Cited by 632
Metadata
- Authors
- Berman, J. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-04-01
- Volume
- 24
- Issue
- 4
- Pages
- 684-703
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2168946125
- Cited by
- 806
- References
- 28
- FWCI
- 43.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.